Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2006-06

AUTHORS

Mónica Vigna-Perez, Berenice Hernández-Castro, Octavio Paredes-Saharopulos, Diana Portales-Pérez, Lourdes Baranda, Carlos Abud-Mendoza, Roberto González-Amaro

ABSTRACT

We studied the clinical and immunological effects of Rituximab (anti-CD20) therapy in patients with lupus nephritis. In an open clinical trial, 22 patients with active systemic lupus erythematosis and renal involvement (mainly class III and IV according to the WHO classification) that was refractory to conventional therapy were studied. In all these patients, Rituximab (0.5 to 1.0 g at days 1 and 15) was added to the immunosuppressive therapy and its therapeutic effect was evaluated. In addition, the levels and function of regulatory T lymphocytes and the apoptosis of immune cells were assessed. We found a significant reduction in disease activity (p < 0.05, MEX-SLEDAI index), and proteinuria (p < 0.05) at days 60 and 90 of Rituximab therapy. Although most patients showed improvement in creatinine clearance and erythrocyturia, no significant changes in these parameters were detected. In most patients (20/22), B cell depletion was observed, but no clear-cut effect of Rituximab on complement levels or auto-antibody titers was detected (p > 0.05 in all cases). One patient died at day 70 with invasive histoplasmosis. No important adverse effects of Rituximab therapy were registered in other patients. A significant enhancement in the levels of different CD4+ regulatory cells (TREG, Th3, Tr1), but not CD8+ Ts lymphocytes, was observed at day 30. This increase was sustained for TREG cells at day 90, and accompanied by an improvement in their regulatory function. In addition, we observed an unexpected increase in the apoptosis of T cells at day 30. Interestingly, the enhancement in the suppressive function of TREG cells was not observed in the two patients that showed the poorest clinical response to Rituximab. We conclude that the data obtained in this open clinical trial suggest that Rituximab is a promising candidate for randomized controlled trials in patients with lupus nephritis refractory to the conventional immunosuppressive therapy. The effects of Rituximab on regulatory cells and apoptosis of T lymphocytes are interesting and its possible role in the putative effect of this biological agent in systemic lupus erythematosis deserves additional studies. More... »

PAGES

r83

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/ar1954

DOI

http://dx.doi.org/10.1186/ar1954

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003531501

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16677395


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Murine-Derived", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antirheumatic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD4-Positive T-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunologic Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lupus Nephritis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methotrexate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rituximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Autonomous University of San Luis Potos\u00ed", 
          "id": "https://www.grid.ac/institutes/grid.412862.b", 
          "name": [
            "Departamento de Inmunolog\u00eda, Facultad de Medicina, UASLP, San Luis Potos\u00ed, SLP, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vigna-Perez", 
        "givenName": "M\u00f3nica", 
        "id": "sg:person.01222250342.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222250342.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Autonomous University of San Luis Potos\u00ed", 
          "id": "https://www.grid.ac/institutes/grid.412862.b", 
          "name": [
            "Departamento de Inmunolog\u00eda, Facultad de Medicina, UASLP, San Luis Potos\u00ed, SLP, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hern\u00e1ndez-Castro", 
        "givenName": "Berenice", 
        "id": "sg:person.01077150665.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077150665.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Autonomous University of San Luis Potos\u00ed", 
          "id": "https://www.grid.ac/institutes/grid.412862.b", 
          "name": [
            "Departamento de Inmunolog\u00eda, Facultad de Medicina, UASLP, San Luis Potos\u00ed, SLP, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paredes-Saharopulos", 
        "givenName": "Octavio", 
        "id": "sg:person.0637634444.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637634444.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Autonomous University of San Luis Potos\u00ed", 
          "id": "https://www.grid.ac/institutes/grid.412862.b", 
          "name": [
            "Laboratorio de Inmunolog\u00eda Celular y Molecular, Facultad de Ciencias Qu\u00edmicas, UASLP, San Luis Potos\u00ed, SLP, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Portales-P\u00e9rez", 
        "givenName": "Diana", 
        "id": "sg:person.01153773541.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153773541.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Central Dr. Ignacio Morones Prieto", 
          "id": "https://www.grid.ac/institutes/grid.414410.4", 
          "name": [
            "Departamento de Inmunolog\u00eda, Facultad de Medicina, UASLP, San Luis Potos\u00ed, SLP, M\u00e9xico", 
            "Unidad Regional de Reumatolog\u00eda y Osteoporosis, Hospital Central Dr Ignacio Morones Prieto, San Luis Potos\u00ed, SLP, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baranda", 
        "givenName": "Lourdes", 
        "id": "sg:person.0706434562.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706434562.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Central Dr. Ignacio Morones Prieto", 
          "id": "https://www.grid.ac/institutes/grid.414410.4", 
          "name": [
            "Unidad Regional de Reumatolog\u00eda y Osteoporosis, Hospital Central Dr Ignacio Morones Prieto, San Luis Potos\u00ed, SLP, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abud-Mendoza", 
        "givenName": "Carlos", 
        "id": "sg:person.01041754035.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041754035.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Autonomous University of San Luis Potos\u00ed", 
          "id": "https://www.grid.ac/institutes/grid.412862.b", 
          "name": [
            "Departamento de Inmunolog\u00eda, Facultad de Medicina, UASLP, San Luis Potos\u00ed, SLP, M\u00e9xico"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gonz\u00e1lez-Amaro", 
        "givenName": "Roberto", 
        "id": "sg:person.01246627327.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246627327.64"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/rheumatology/keh618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002093065"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/keh443", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002529784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.165.10.5970", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003764385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/kei080", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004301803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.10541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004571121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.20031579", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004960961"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.20040165", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005439923"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.bor.0000170479.01451.ab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007566067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.bor.0000170479.01451.ab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007566067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.bor.0000170479.01451.ab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007566067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200211002-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009041921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00001813-200211002-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009041921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/1074-7613(95)90161-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010596773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2249.2005.02859.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012397631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2249.2005.02859.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012397631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1034/j.1600-065x.2001.1820105.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012676651"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0804-801", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014073897", 
          "https://doi.org/10.1038/nm0804-801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0804-801", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014073897", 
          "https://doi.org/10.1038/nm0804-801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/03009740410010227", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015438982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21351", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016675988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21351", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016675988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar1007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018679330", 
          "https://doi.org/10.1186/ar1007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018844754"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.11063", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020708763"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar1192", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021099528", 
          "https://doi.org/10.1186/ar1192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-065x.1999.tb01310.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021910023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-5699(91)90094-a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021915365"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2004.029694", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022309174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.10192", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025825370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ni0901-816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027284442", 
          "https://doi.org/10.1038/ni0901-816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ni0901-816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027284442", 
          "https://doi.org/10.1038/ni0901-816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20976", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028508707"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20858", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029058898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mai.2000.106635", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029570360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.2334901100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034837935"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0896-8411(03)00121-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036311060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0896-8411(03)00121-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036311060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.10764", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039534151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/sonc.2002.30156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041461608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20500", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042034642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045095887"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.0300-9475.2004.01370.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050787169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20430", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051828584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/intimm/10.6.775", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052703784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199406303302608", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053336179"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.181.3.839", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058438599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1191/0961203303lu449cr", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064154350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1191/0961203303lu449cr", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064154350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1191/0961203303lu449cr", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064154350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1615/critrevimmunol.v25.i2.30", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068131861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.166.10.5955", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074810677"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.166.10.6452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074810742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.176.3.1316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077177439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078803696", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080037334", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082444072", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-06", 
    "datePublishedReg": "2006-06-01", 
    "description": "We studied the clinical and immunological effects of Rituximab (anti-CD20) therapy in patients with lupus nephritis. In an open clinical trial, 22 patients with active systemic lupus erythematosis and renal involvement (mainly class III and IV according to the WHO classification) that was refractory to conventional therapy were studied. In all these patients, Rituximab (0.5 to 1.0 g at days 1 and 15) was added to the immunosuppressive therapy and its therapeutic effect was evaluated. In addition, the levels and function of regulatory T lymphocytes and the apoptosis of immune cells were assessed. We found a significant reduction in disease activity (p < 0.05, MEX-SLEDAI index), and proteinuria (p < 0.05) at days 60 and 90 of Rituximab therapy. Although most patients showed improvement in creatinine clearance and erythrocyturia, no significant changes in these parameters were detected. In most patients (20/22), B cell depletion was observed, but no clear-cut effect of Rituximab on complement levels or auto-antibody titers was detected (p > 0.05 in all cases). One patient died at day 70 with invasive histoplasmosis. No important adverse effects of Rituximab therapy were registered in other patients. A significant enhancement in the levels of different CD4+ regulatory cells (TREG, Th3, Tr1), but not CD8+ Ts lymphocytes, was observed at day 30. This increase was sustained for TREG cells at day 90, and accompanied by an improvement in their regulatory function. In addition, we observed an unexpected increase in the apoptosis of T cells at day 30. Interestingly, the enhancement in the suppressive function of TREG cells was not observed in the two patients that showed the poorest clinical response to Rituximab. We conclude that the data obtained in this open clinical trial suggest that Rituximab is a promising candidate for randomized controlled trials in patients with lupus nephritis refractory to the conventional immunosuppressive therapy. The effects of Rituximab on regulatory cells and apoptosis of T lymphocytes are interesting and its possible role in the putative effect of this biological agent in systemic lupus erythematosis deserves additional studies.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/ar1954", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1297499", 
        "issn": [
          "1478-6354", 
          "1478-6362"
        ], 
        "name": "Arthritis Research & Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study", 
    "pagination": "r83", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "10d2a07af7316cdbd0ae12b167d8aa2091eba61e4e5ba7d30d21c5d7f763417d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16677395"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101154438"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/ar1954"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003531501"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/ar1954", 
      "https://app.dimensions.ai/details/publication/pub.1003531501"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Far1954"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/ar1954'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/ar1954'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/ar1954'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/ar1954'


 

This table displays all metadata directly associated to this object as RDF triples.

327 TRIPLES      21 PREDICATES      93 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/ar1954 schema:about N0df8b38364354b6db67720a0720e8f96
2 N0e69821858e14e04baca7aaca5a1f0ef
3 N24a6cac52c274eb7ba1fd437fcddb44e
4 N32ff08e077f4419e8f15fc7406a12ab2
5 N3446d887954b49efab0d9d30c9a6b570
6 N5b9694dfdfbc4c62aea0244cd715b5a0
7 N5e79d9749fe84d2aa261d5750458acd7
8 N661ed574af9d403a83c11be600aabe0b
9 N710006c0c67d4147a99537f086335039
10 N8c8bfdab732d481d87cf703b67384793
11 N91eb0a0682d245858c2870db47e7e480
12 N9aadac452a0e4086b7e3732c807bf097
13 Nb836fbac4d0d42dc9b416e8641a8f7fa
14 Nc270de5d87fb4188a6e31ecc3cee5100
15 Nd81dcf0890c04307b7bec43b495914d7
16 Nde8a465ec1bb4e28bee351ab8efcdc3a
17 Nf5dd2fcb0dc14adfbcadf9072d35d24e
18 Nffbb2039e9ef4d58bc6d1a7c8af8e4c3
19 anzsrc-for:11
20 anzsrc-for:1107
21 schema:author Ne2fa073ba3dc40d29a9ab9cbbacf699e
22 schema:citation sg:pub.10.1038/ni0901-816
23 sg:pub.10.1038/nm0804-801
24 sg:pub.10.1186/ar1007
25 sg:pub.10.1186/ar1192
26 https://app.dimensions.ai/details/publication/pub.1078803696
27 https://app.dimensions.ai/details/publication/pub.1080037334
28 https://app.dimensions.ai/details/publication/pub.1082444072
29 https://doi.org/10.1002/art.10192
30 https://doi.org/10.1002/art.10541
31 https://doi.org/10.1002/art.10764
32 https://doi.org/10.1002/art.11063
33 https://doi.org/10.1002/art.20430
34 https://doi.org/10.1002/art.20500
35 https://doi.org/10.1002/art.20592
36 https://doi.org/10.1002/art.20857
37 https://doi.org/10.1002/art.20858
38 https://doi.org/10.1002/art.20976
39 https://doi.org/10.1002/art.21351
40 https://doi.org/10.1016/0167-5699(91)90094-a
41 https://doi.org/10.1016/1074-7613(95)90161-2
42 https://doi.org/10.1016/s0896-8411(03)00121-5
43 https://doi.org/10.1034/j.1600-065x.2001.1820105.x
44 https://doi.org/10.1053/sonc.2002.30156
45 https://doi.org/10.1056/nejm199406303302608
46 https://doi.org/10.1067/mai.2000.106635
47 https://doi.org/10.1073/pnas.2334901100
48 https://doi.org/10.1080/03009740410010227
49 https://doi.org/10.1084/jem.181.3.839
50 https://doi.org/10.1084/jem.20031579
51 https://doi.org/10.1084/jem.20040165
52 https://doi.org/10.1093/intimm/10.6.775
53 https://doi.org/10.1093/rheumatology/keh443
54 https://doi.org/10.1093/rheumatology/keh618
55 https://doi.org/10.1093/rheumatology/kei080
56 https://doi.org/10.1097/00001813-200211002-00002
57 https://doi.org/10.1097/01.bor.0000170479.01451.ab
58 https://doi.org/10.1111/j.0300-9475.2004.01370.x
59 https://doi.org/10.1111/j.1365-2249.2005.02859.x
60 https://doi.org/10.1111/j.1600-065x.1999.tb01310.x
61 https://doi.org/10.1136/ard.2004.029694
62 https://doi.org/10.1191/0961203303lu449cr
63 https://doi.org/10.1615/critrevimmunol.v25.i2.30
64 https://doi.org/10.4049/jimmunol.165.10.5970
65 https://doi.org/10.4049/jimmunol.166.10.5955
66 https://doi.org/10.4049/jimmunol.166.10.6452
67 https://doi.org/10.4049/jimmunol.176.3.1316
68 schema:datePublished 2006-06
69 schema:datePublishedReg 2006-06-01
70 schema:description We studied the clinical and immunological effects of Rituximab (anti-CD20) therapy in patients with lupus nephritis. In an open clinical trial, 22 patients with active systemic lupus erythematosis and renal involvement (mainly class III and IV according to the WHO classification) that was refractory to conventional therapy were studied. In all these patients, Rituximab (0.5 to 1.0 g at days 1 and 15) was added to the immunosuppressive therapy and its therapeutic effect was evaluated. In addition, the levels and function of regulatory T lymphocytes and the apoptosis of immune cells were assessed. We found a significant reduction in disease activity (p < 0.05, MEX-SLEDAI index), and proteinuria (p < 0.05) at days 60 and 90 of Rituximab therapy. Although most patients showed improvement in creatinine clearance and erythrocyturia, no significant changes in these parameters were detected. In most patients (20/22), B cell depletion was observed, but no clear-cut effect of Rituximab on complement levels or auto-antibody titers was detected (p > 0.05 in all cases). One patient died at day 70 with invasive histoplasmosis. No important adverse effects of Rituximab therapy were registered in other patients. A significant enhancement in the levels of different CD4+ regulatory cells (TREG, Th3, Tr1), but not CD8+ Ts lymphocytes, was observed at day 30. This increase was sustained for TREG cells at day 90, and accompanied by an improvement in their regulatory function. In addition, we observed an unexpected increase in the apoptosis of T cells at day 30. Interestingly, the enhancement in the suppressive function of TREG cells was not observed in the two patients that showed the poorest clinical response to Rituximab. We conclude that the data obtained in this open clinical trial suggest that Rituximab is a promising candidate for randomized controlled trials in patients with lupus nephritis refractory to the conventional immunosuppressive therapy. The effects of Rituximab on regulatory cells and apoptosis of T lymphocytes are interesting and its possible role in the putative effect of this biological agent in systemic lupus erythematosis deserves additional studies.
71 schema:genre research_article
72 schema:inLanguage en
73 schema:isAccessibleForFree true
74 schema:isPartOf N1dcd0f1e653444b2bc860e5ae34c51fa
75 N48c999120a1a47c4a55e162db056c37d
76 sg:journal.1297499
77 schema:name Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study
78 schema:pagination r83
79 schema:productId N16348be79e404cf0b9fec318c72c5b3b
80 N5cee29c5cb0e49f28b5a85fa0fa3d951
81 N7e2aef95fcaf4f179be7a6170ddd7deb
82 Ncd79b86e87bc42ba93ea6780ba286c94
83 Ne67c849d981c4d84b6d5b0c5c30288a4
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003531501
85 https://doi.org/10.1186/ar1954
86 schema:sdDatePublished 2019-04-10T18:19
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher N7c56834ed74947cc9f259a4bae700da4
89 schema:url http://link.springer.com/10.1186%2Far1954
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N0df8b38364354b6db67720a0720e8f96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name CD4-Positive T-Lymphocytes
95 rdf:type schema:DefinedTerm
96 N0e69821858e14e04baca7aaca5a1f0ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name T-Lymphocytes
98 rdf:type schema:DefinedTerm
99 N16348be79e404cf0b9fec318c72c5b3b schema:name readcube_id
100 schema:value 10d2a07af7316cdbd0ae12b167d8aa2091eba61e4e5ba7d30d21c5d7f763417d
101 rdf:type schema:PropertyValue
102 N1dcd0f1e653444b2bc860e5ae34c51fa schema:volumeNumber 8
103 rdf:type schema:PublicationVolume
104 N24a6cac52c274eb7ba1fd437fcddb44e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Apoptosis
106 rdf:type schema:DefinedTerm
107 N2f5688ac8ba9476b9355433e07ff910e rdf:first sg:person.01246627327.64
108 rdf:rest rdf:nil
109 N32ff08e077f4419e8f15fc7406a12ab2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Lymphocyte Activation
111 rdf:type schema:DefinedTerm
112 N3446d887954b49efab0d9d30c9a6b570 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Antibodies, Monoclonal
114 rdf:type schema:DefinedTerm
115 N48c999120a1a47c4a55e162db056c37d schema:issueNumber 3
116 rdf:type schema:PublicationIssue
117 N5b9694dfdfbc4c62aea0244cd715b5a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Immunologic Factors
119 rdf:type schema:DefinedTerm
120 N5cee29c5cb0e49f28b5a85fa0fa3d951 schema:name pubmed_id
121 schema:value 16677395
122 rdf:type schema:PropertyValue
123 N5e79d9749fe84d2aa261d5750458acd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Adult
125 rdf:type schema:DefinedTerm
126 N661ed574af9d403a83c11be600aabe0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Rituximab
128 rdf:type schema:DefinedTerm
129 N710006c0c67d4147a99537f086335039 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Antibodies, Monoclonal, Murine-Derived
131 rdf:type schema:DefinedTerm
132 N7c56834ed74947cc9f259a4bae700da4 schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 N7e2aef95fcaf4f179be7a6170ddd7deb schema:name nlm_unique_id
135 schema:value 101154438
136 rdf:type schema:PropertyValue
137 N84ae053aac4d4be2a3fafaa5d4865df8 rdf:first sg:person.01041754035.29
138 rdf:rest N2f5688ac8ba9476b9355433e07ff910e
139 N8c8bfdab732d481d87cf703b67384793 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Lupus Nephritis
141 rdf:type schema:DefinedTerm
142 N91eb0a0682d245858c2870db47e7e480 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Methotrexate
144 rdf:type schema:DefinedTerm
145 N9aadac452a0e4086b7e3732c807bf097 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Male
147 rdf:type schema:DefinedTerm
148 Na20ea573e05d45aebc9db7b244d84a6e rdf:first sg:person.01077150665.84
149 rdf:rest Nc4279463d06a45979516133fbe82f17e
150 Nb836fbac4d0d42dc9b416e8641a8f7fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Pilot Projects
152 rdf:type schema:DefinedTerm
153 Nc270de5d87fb4188a6e31ecc3cee5100 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Drug Therapy, Combination
155 rdf:type schema:DefinedTerm
156 Nc4279463d06a45979516133fbe82f17e rdf:first sg:person.0637634444.29
157 rdf:rest Nd4a85c79be8644c98218cc0ae804b24f
158 Nc59171e0aba44e9ea043d885578d9fb5 rdf:first sg:person.0706434562.05
159 rdf:rest N84ae053aac4d4be2a3fafaa5d4865df8
160 Ncd79b86e87bc42ba93ea6780ba286c94 schema:name dimensions_id
161 schema:value pub.1003531501
162 rdf:type schema:PropertyValue
163 Nd4a85c79be8644c98218cc0ae804b24f rdf:first sg:person.01153773541.25
164 rdf:rest Nc59171e0aba44e9ea043d885578d9fb5
165 Nd81dcf0890c04307b7bec43b495914d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Female
167 rdf:type schema:DefinedTerm
168 Nde8a465ec1bb4e28bee351ab8efcdc3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Middle Aged
170 rdf:type schema:DefinedTerm
171 Ne2fa073ba3dc40d29a9ab9cbbacf699e rdf:first sg:person.01222250342.52
172 rdf:rest Na20ea573e05d45aebc9db7b244d84a6e
173 Ne67c849d981c4d84b6d5b0c5c30288a4 schema:name doi
174 schema:value 10.1186/ar1954
175 rdf:type schema:PropertyValue
176 Nf5dd2fcb0dc14adfbcadf9072d35d24e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Humans
178 rdf:type schema:DefinedTerm
179 Nffbb2039e9ef4d58bc6d1a7c8af8e4c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Antirheumatic Agents
181 rdf:type schema:DefinedTerm
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
186 schema:name Immunology
187 rdf:type schema:DefinedTerm
188 sg:journal.1297499 schema:issn 1478-6354
189 1478-6362
190 schema:name Arthritis Research & Therapy
191 rdf:type schema:Periodical
192 sg:person.01041754035.29 schema:affiliation https://www.grid.ac/institutes/grid.414410.4
193 schema:familyName Abud-Mendoza
194 schema:givenName Carlos
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041754035.29
196 rdf:type schema:Person
197 sg:person.01077150665.84 schema:affiliation https://www.grid.ac/institutes/grid.412862.b
198 schema:familyName Hernández-Castro
199 schema:givenName Berenice
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077150665.84
201 rdf:type schema:Person
202 sg:person.01153773541.25 schema:affiliation https://www.grid.ac/institutes/grid.412862.b
203 schema:familyName Portales-Pérez
204 schema:givenName Diana
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153773541.25
206 rdf:type schema:Person
207 sg:person.01222250342.52 schema:affiliation https://www.grid.ac/institutes/grid.412862.b
208 schema:familyName Vigna-Perez
209 schema:givenName Mónica
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222250342.52
211 rdf:type schema:Person
212 sg:person.01246627327.64 schema:affiliation https://www.grid.ac/institutes/grid.412862.b
213 schema:familyName González-Amaro
214 schema:givenName Roberto
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246627327.64
216 rdf:type schema:Person
217 sg:person.0637634444.29 schema:affiliation https://www.grid.ac/institutes/grid.412862.b
218 schema:familyName Paredes-Saharopulos
219 schema:givenName Octavio
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637634444.29
221 rdf:type schema:Person
222 sg:person.0706434562.05 schema:affiliation https://www.grid.ac/institutes/grid.414410.4
223 schema:familyName Baranda
224 schema:givenName Lourdes
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706434562.05
226 rdf:type schema:Person
227 sg:pub.10.1038/ni0901-816 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027284442
228 https://doi.org/10.1038/ni0901-816
229 rdf:type schema:CreativeWork
230 sg:pub.10.1038/nm0804-801 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014073897
231 https://doi.org/10.1038/nm0804-801
232 rdf:type schema:CreativeWork
233 sg:pub.10.1186/ar1007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018679330
234 https://doi.org/10.1186/ar1007
235 rdf:type schema:CreativeWork
236 sg:pub.10.1186/ar1192 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021099528
237 https://doi.org/10.1186/ar1192
238 rdf:type schema:CreativeWork
239 https://app.dimensions.ai/details/publication/pub.1078803696 schema:CreativeWork
240 https://app.dimensions.ai/details/publication/pub.1080037334 schema:CreativeWork
241 https://app.dimensions.ai/details/publication/pub.1082444072 schema:CreativeWork
242 https://doi.org/10.1002/art.10192 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025825370
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1002/art.10541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004571121
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1002/art.10764 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039534151
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1002/art.11063 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020708763
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1002/art.20430 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051828584
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1002/art.20500 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042034642
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1002/art.20592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045095887
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1002/art.20857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018844754
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1002/art.20858 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029058898
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1002/art.20976 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028508707
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1002/art.21351 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016675988
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1016/0167-5699(91)90094-a schema:sameAs https://app.dimensions.ai/details/publication/pub.1021915365
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1016/1074-7613(95)90161-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010596773
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1016/s0896-8411(03)00121-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036311060
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1034/j.1600-065x.2001.1820105.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012676651
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1053/sonc.2002.30156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041461608
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1056/nejm199406303302608 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053336179
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1067/mai.2000.106635 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029570360
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1073/pnas.2334901100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034837935
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1080/03009740410010227 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015438982
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1084/jem.181.3.839 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058438599
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1084/jem.20031579 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004960961
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1084/jem.20040165 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005439923
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1093/intimm/10.6.775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052703784
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1093/rheumatology/keh443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002529784
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1093/rheumatology/keh618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002093065
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1093/rheumatology/kei080 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004301803
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1097/00001813-200211002-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009041921
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1097/01.bor.0000170479.01451.ab schema:sameAs https://app.dimensions.ai/details/publication/pub.1007566067
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1111/j.0300-9475.2004.01370.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050787169
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1111/j.1365-2249.2005.02859.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012397631
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1111/j.1600-065x.1999.tb01310.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1021910023
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1136/ard.2004.029694 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022309174
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1191/0961203303lu449cr schema:sameAs https://app.dimensions.ai/details/publication/pub.1064154350
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1615/critrevimmunol.v25.i2.30 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068131861
311 rdf:type schema:CreativeWork
312 https://doi.org/10.4049/jimmunol.165.10.5970 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003764385
313 rdf:type schema:CreativeWork
314 https://doi.org/10.4049/jimmunol.166.10.5955 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074810677
315 rdf:type schema:CreativeWork
316 https://doi.org/10.4049/jimmunol.166.10.6452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074810742
317 rdf:type schema:CreativeWork
318 https://doi.org/10.4049/jimmunol.176.3.1316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077177439
319 rdf:type schema:CreativeWork
320 https://www.grid.ac/institutes/grid.412862.b schema:alternateName Autonomous University of San Luis Potosí
321 schema:name Departamento de Inmunología, Facultad de Medicina, UASLP, San Luis Potosí, SLP, México
322 Laboratorio de Inmunología Celular y Molecular, Facultad de Ciencias Químicas, UASLP, San Luis Potosí, SLP, México
323 rdf:type schema:Organization
324 https://www.grid.ac/institutes/grid.414410.4 schema:alternateName Hospital Central Dr. Ignacio Morones Prieto
325 schema:name Departamento de Inmunología, Facultad de Medicina, UASLP, San Luis Potosí, SLP, México
326 Unidad Regional de Reumatología y Osteoporosis, Hospital Central Dr Ignacio Morones Prieto, San Luis Potosí, SLP, México
327 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...